WebBioGaia AB: Interim report third quarter January – September 2024. THIRD QUARTER 2024 · Net sales amounted to SEK 257.7 million (173.8), an increase of SEK 83.9 million, or 48% (excluding foreign exchange effects, 33%) of which the acquisition of Nutraceutics accounted for an increase of SEK 20.8 million (12%). Organic growth was 21%. WebBioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for …
BioGaia AG ADR (BIOGY) Stock Price, Quote, News & History
WebBioGaia AB: Interim report third quarter January – September 2024. THIRD QUARTER 2024 · Net sales amounted to SEK 257.7 million (173.8), an increase of SEK 83.9 … WebDec 31, 2024 · On 1 January 2012, the shares were moved from the Small Cap List to the Mid Cap List. In 2024, an average of 28,852 shares were trading each day for an average of SEK 13,208,910 per day. The number of shareholders at 31 December 2024 was 8,709 (9,064). The total registered share capital of BioGaia AB consists of 3,703,340 class A … cinemark movie theater myrtle beach sc
Finansiell Information - Elos Medtech
WebMay 4, 2024 · Investor Relations; ESG Reporting Guide; European Markets; Nasdaq Nordic Foundation; Nasdaq Thought Leadership; Nasdaq Initiatives The Purpose … WebFeb 28, 2024 · Investor Relations. Joseph Suarez Vice President, Investor Relations T: 773-551-4397 [email protected]. David Paccapaniccia Analyst, Senior Investor Relations T: 585-282-7227 [email protected]. Snehal Shah Director, Investor Relations T: 847-385-4940 [email protected] WebBioGaia is a world-leading Swedish healthcare company that has been at the forefront of microbiome research for more than 30 years, developing, marketing and selling clinically … diabetic weekly meal planning site